Biomedical & Medtech Manufacturing
Lonza Biologics Tuas
UNCLAIMED RECORD · Claim it →A large mammalian cell-culture CDMO campus at Tuas producing monoclonal antibodies and recombinant and fusion proteins across 20,000-litre stainless-steel and 2,000-litre single-use suites, with cell-line construction through commercial process validation, purification, viral clearance and fill, plus an allogeneic cell-therapy centre of excellence and a strong regulatory-inspection record.
Capabilities
Sources
CLAIM THIS RECORD
Is this your company?
Lonza Biologics Tuas is on the Singapore Industry Index as a reference record, compiled from public sources. Claiming it is free — correct the facts, add capabilities and certifications, appear on more pages, and receive enquiries routed directly to you.
Spotted an error? Claiming is the fastest way to fix it — or write to us via Contact.